FANCG Antibody

What is FANCG and why is it significant in biomedical research?

FANCG (Fanconi Anemia Complementation Group G) is a critical protein in the Fanconi anemia (FA) pathway that plays an essential role in the repair of DNA interstrand cross-links, thereby maintaining genomic stability. Deficiencies in FANCG can lead to increased susceptibility to DNA damage, resulting in hallmark features of Fanconi anemia such as bone marrow failure and chromosomal instability. FANCG is primarily localized in the nucleus where it participates in DNA repair processes, though it is also expressed in the cytoplasm with higher levels found in the testis and thymus . Within the FA core complex, FANCG interacts with BRCA1 and BRCA2, the proteins encoded by two major hereditary breast/ovarian cancer predisposition genes . These interactions make FANCG antibodies valuable tools for studying DNA repair mechanisms and understanding the molecular basis of Fanconi anemia and potential cancer connections.

What types of FANCG antibodies are commercially available for research?

Researchers have access to multiple types of FANCG antibodies with varying specifications:

Additionally, antibodies are available in both non-conjugated forms and various conjugated formats including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor conjugates to accommodate diverse experimental designs .

What are the validated applications for FANCG antibodies?

FANCG antibodies have been validated for multiple experimental applications:

• Western blotting (WB) for protein detection and quantification

• Immunoprecipitation (IP) for studying protein-protein interactions

• Immunofluorescence (IF) for subcellular localization studies

• Enzyme-linked immunosorbent assay (ELISA) for quantitative measurements

• Immunohistochemistry (IHC) for tissue localization

These applications enable researchers to investigate various aspects of FANCG biology, from expression levels and localization to interaction partners and functional roles in different cellular contexts.

How can FANCG antibodies be used to investigate DNA repair mechanisms?

FANCG antibodies serve as critical tools for probing the Fanconi anemia DNA repair pathway. Methodologically, researchers can:

• Analyze FANCG localization to DNA damage sites:

  • Treat cells with DNA-damaging agents (e.g., mitomycin C)

  • Perform immunofluorescence using FANCG antibodies

  • Quantify nuclear foci formation and co-localization with other DNA repair proteins

• Assess FANCG-dependent FANCD2 activation:

  • Western blotting with FANCD2 antibodies can detect FANCD2 monoubiquitination (a larger molecular weight band) following DNA damage

  • Compare this process in cells expressing wild-type versus mutant FANCG

  • Use FANCG antibodies to confirm expression levels of wild-type or variant FANCG proteins

• Investigate protein complex assembly:

  • Use co-immunoprecipitation with FANCG antibodies to pull down interaction partners

  • Analyze components of the FA core complex under various conditions

  • Study how DNA damage affects FANCG interactions with other proteins

This approach has been successfully employed in research evaluating FANCG variants, demonstrating that truncating mutations disrupt DNA repair activity while many missense variants retain function .

What experimental approaches can validate functional consequences of FANCG variants?

Based on recent research methodologies, functional validation of FANCG variants can be performed using antibody-based techniques:

• FANCD2 monoubiquitination assessment:

  • Generate FANCG-knockout cell lines using CRISPR/Cas9 (targeting exons 1 and 4)

  • Reconstitute cells with wild-type or variant FANCG expression constructs

  • Treat with mitomycin C (MMC) to induce DNA damage

  • Use Western blotting to evaluate FANCD2 monoubiquitination

• FANCD2 nuclear foci formation:

  • Treat reconstituted cells with DNA-damaging agents

  • Perform immunofluorescence with FANCD2 antibodies

  • Quantify nuclear foci using high-content microscopy (e.g., ScanR)

• Functional survival assays:

  • Perform colony formation assays with cells expressing FANCG variants

  • Treat with increasing concentrations of DNA crosslinking agents

  • Compare survival rates between wild-type and variant FANCG

How can researchers investigate post-translational modifications of FANCG?

Post-translational modifications, particularly phosphorylation, are critical for FANCG function. Phosphorylation at serine 7 has been identified as a key modification influencing FA pathway activity . To study these modifications:

• Use phosphorylation-specific antibodies:

  • Western blotting with phospho-specific antibodies targeting known sites (e.g., Ser7)

  • Compare phosphorylation status before and after DNA damage

  • Use phosphatase treatments as controls to confirm specificity

• Analyze effects on protein interactions:

  • Immunoprecipitate FANCG using standard antibodies

  • Compare interaction partners when FANCG is phosphorylated versus unphosphorylated

  • Employ phospho-mimetic mutants (S→D/E) or phospho-dead mutants (S→A) to validate findings

• Correlate with functional outcomes:

  • Monitor how phosphorylation status affects FANCD2 monoubiquitination

  • Assess impact on nuclear localization and foci formation

  • Determine influence on cellular sensitivity to DNA-damaging agents

This approach provides mechanistic insights into how post-translational regulation affects FANCG function in the DNA repair pathway.

What are the critical validation steps for FANCG antibodies?

Proper validation of FANCG antibodies is essential for reliable experimental results:

• Specificity validation:

  • Test antibodies in FANCG knockout or knockdown cells (negative control)

  • Compare reactivity in cells overexpressing FANCG (positive control)

  • Perform peptide competition assays to confirm epitope specificity

  • For polyclonal antibodies, consider affinity purification against the immunizing peptide

• Application-specific validation:

  • For Western blotting: Verify correct molecular weight (~65 kDa for human FANCG)

  • For immunofluorescence: Confirm expected subcellular localization (primarily nuclear)

  • For immunoprecipitation: Demonstrate enrichment of known interaction partners

• Cross-reactivity assessment:

  • Test in multiple species if working across model systems

  • Verify species reactivity claims with appropriate positive controls

  • Consider potential cross-reactivity with other TPR-containing proteins

• Lot-to-lot consistency:

  • Test new antibody lots against previously validated lots

  • Maintain reference samples for comparison

These validation steps ensure experimental reliability and reproducibility when working with FANCG antibodies.

What are common technical challenges with FANCG immunofluorescence and how can they be addressed?

When performing immunofluorescence with FANCG antibodies, researchers may encounter several challenges:

• Low signal-to-noise ratio:

  • Optimize fixation method (4% paraformaldehyde typically works well)

  • Test different permeabilization conditions (0.1-0.5% Triton X-100)

  • Increase blocking duration (1-2 hours) with 5% BSA or normal serum

  • Optimize primary antibody concentration (try 1:100 to 1:500 dilutions)

  • Extend primary antibody incubation (overnight at 4°C)

• Difficulty detecting nuclear foci:

  • Induce DNA damage with appropriate agents (e.g., mitomycin C)

  • Use high-NA objectives (60x or 100x) for resolving small foci

  • Consider deconvolution or super-resolution microscopy

  • Co-stain with established DNA damage markers (γH2AX, FANCD2)

• Background autofluorescence:

  • Include untreated and secondary-only controls

  • Use Sudan Black B (0.1% in 70% ethanol) to quench autofluorescence

  • Consider fluorophores with emission spectra distant from cellular autofluorescence

• Quantification challenges:

  • Use automated high-content imaging systems for unbiased analysis

  • Establish clear criteria for foci counting (size, intensity thresholds)

  • Analyze multiple fields and sufficient cell numbers for statistical power

These approaches have been successfully applied in research examining FANCG variant effects on FANCD2 foci formation following DNA damage .

What considerations are important when designing Western blotting experiments with FANCG antibodies?

Successful Western blotting with FANCG antibodies requires attention to several key factors:

• Sample preparation:

  • Include protease inhibitors to prevent degradation

  • Consider phosphatase inhibitors if studying phosphorylated forms

  • Use RIPA or NP-40 buffers for efficient extraction

  • Sonicate samples to shear DNA and reduce viscosity

• Gel electrophoresis and transfer:

  • Use 8-10% polyacrylamide gels for optimal resolution

  • Consider wet transfer for more efficient transfer of higher molecular weight proteins

  • Transfer at lower voltage for longer time to ensure complete transfer

• Antibody incubation:

  • Block thoroughly (5% non-fat milk or BSA in TBST)

  • Optimize primary antibody dilution (typically 1:500 to 1:2000)

  • Incubate primary antibody overnight at 4°C for best results

  • Wash extensively (4-5 times, 5-10 minutes each) before secondary antibody

• Controls and validation:

  • Include molecular weight markers

  • Use positive control samples with known FANCG expression

  • Consider FANCG-knockout or knockdown samples as negative controls

  • Include loading controls (β-actin, GAPDH) for normalization

These methodological considerations ensure reliable detection of FANCG protein in Western blotting applications.

How do FANCG antibodies contribute to Fanconi anemia research?

FANCG antibodies serve as essential tools in Fanconi anemia research through multiple methodological approaches:

• Diagnosis and classification:

  • Western blotting with FANCG antibodies can help identify FA-G patients

  • Analysis of FANCG protein expression levels and molecular weight can detect truncations

  • Complement functional tests like chromosome breakage analysis

• Genotype-phenotype correlation studies:

  • Compare FANCG protein expression and function across patients with different mutations

  • Correlate protein levels/function with clinical manifestations

  • Analyze how specific domains affect protein interactions and pathway activity

• Therapeutic development:

  • Screen compounds that might stabilize mutant FANCG proteins

  • Evaluate gene therapy approaches by confirming FANCG expression

  • Monitor protein restoration in cell models after therapeutic intervention

• Basic disease mechanism studies:

  • Investigate how FANCG deficiency affects DNA repair processes

  • Study interactions with other FA proteins in patient-derived cells

  • Examine tissue-specific effects of FANCG mutations

These applications provide critical insights into disease mechanisms and potential therapeutic approaches for Fanconi anemia.

What evidence exists regarding FANCG's role in cancer, and how have antibodies contributed to this research?

Recent research has investigated the potential role of FANCG in cancer predisposition, with antibody-based methods providing key insights:

These findings, heavily dependent on antibody-based methodologies, collectively suggest that heterozygous germline FANCG variants are unlikely to contribute significantly to breast or ovarian cancer development, contrary to some other Fanconi anemia genes like BRCA1/BRCA2 .

How can FANCG antibodies be utilized in comparative studies across different FA complementation groups?

FANCG antibodies enable sophisticated comparative analyses across FA complementation groups:

• Protein complex assembly analysis:

  • Immunoprecipitate core complex components from different FA subtypes

  • Use Western blotting with FANCG antibodies to assess complex formation

  • Compare how different FA mutations affect FANCG incorporation into complexes

• Pathway activation studies:

  • Analyze FANCD2 monoubiquitination in cells with defects in different FA genes

  • Use FANCG antibodies to determine if FANCG localization is affected

  • Compare nuclear focus formation of FANCG across complementation groups

• Epistasis experiments:

  • Create cell lines with multiple FA gene deficiencies

  • Use FANCG antibodies to monitor protein expression and localization

  • Determine hierarchical relationships between different FA proteins

• Therapeutic response comparison:

  • Test potential FA therapeutics across complementation groups

  • Use FANCG antibodies to monitor effects on protein stability and interactions

  • Identify complementation group-specific versus general therapeutic approaches

These comparative approaches provide insights into the functional relationships between different FA genes and their protein products.

How can FANCG antibodies be employed in single-cell analysis techniques?

Emerging single-cell technologies offer new applications for FANCG antibodies:

• Mass cytometry (CyTOF):

  • Conjugate FANCG antibodies with rare metal isotopes

  • Combine with other DNA repair protein markers for multiplexed analysis

  • Analyze heterogeneity in FANCG expression and phosphorylation at single-cell resolution

  • Correlate with cell cycle markers and DNA damage indicators

• Single-cell Western blotting:

  • Capture individual cells in microwell arrays

  • Lyse cells and separate proteins by size

  • Probe with FANCG antibodies to detect expression variability

  • Correlate with functional readouts at single-cell level

• Imaging mass cytometry:

  • Use metal-conjugated FANCG antibodies on tissue sections

  • Achieve subcellular resolution of FANCG localization in tissue context

  • Correlate with pathological features and other protein markers

• Proximity ligation assays:

  • Detect protein-protein interactions at single-molecule resolution

  • Identify rare interaction events that might be missed in bulk analyses

  • Quantify spatial relationships between FANCG and other proteins

These emerging methods enable unprecedented resolution in studying FANCG biology at the single-cell level.

What are the methodological considerations when studying FANCG in primary patient samples?

Working with primary patient samples presents unique challenges for FANCG antibody applications:

• Sample preservation and preparation:

  • Optimize fixation protocols for different sample types

  • Consider rapid preservation methods to prevent degradation

  • Test different extraction buffers for maximum protein recovery

  • Adjust protocols based on sample limitation

• Signal amplification strategies:

  • Use tyramide signal amplification for immunohistochemistry

  • Consider proximity ligation assays for detecting low-abundance interactions

  • Employ higher sensitivity Western blotting methods (chemiluminescence)

  • Optimize antibody concentration for limited material

• Multiplexed analysis approaches:

  • Develop sequential staining protocols for multiple markers

  • Use spectral unmixing for multiple fluorophores

  • Consider multiplex immunohistochemistry methods

  • Correlate with other molecular data (genomics, transcriptomics)

• Controls and standardization:

  • Include reference cell lines with known FANCG expression

  • Standardize protocols across patient samples

  • Account for preanalytical variables (time to fixation, processing methods)

  • Consider batch effects in analysis

These methodological considerations ensure reliable FANCG analysis in valuable patient samples.